5-Methoxytryptamine (5-MeO-DMT)(link:https://www.bloomtechz.com/synthetic-chemical/api-researching-only/5-methoxytryptamine-cas-608-07-1.html) is a compound containing an aromatic ring and an amine group, belonging to the reagent class methoxy derivatives of lysergic acid dimethyltriester (DMT). When analyzing molecular structure, it can be described from multiple aspects such as molecular formula, structural formula, spatial configuration, and functional groups.
1. Molecular formula:
The molecular formula of 5-Methoxytryptamine is C13H16N2O, which contains 13 carbon atoms, 16 hydrogen atoms, 2 nitrogen atoms and 1 oxygen atom. The molecular formula provides information about the overall chemical composition.
2. Structural formula:
The structural formula of 5-Methoxytryptamine is as follows:

Structural formulas show how the atoms in a molecule are connected and the relationships between them. In the structural formula of 5-Methoxytryptamine, you can see the methoxy group (CH3O) and amine group (NH2) on the aromatic ring, as well as the methyl group (CH3) connected to the aromatic ring.
3. Spatial configuration:
The spatial configuration of the 5-Methoxytryptamine molecule is determined by the bond angles between atoms and the orientation of the chiral centers. However, in the absence of specific experimental data and analysis, it is difficult to derive a definite spatial configuration. In general, speculation can be made based on molecular configuration models and theoretical methods. In amine compounds with chiral centers, there are two possible configurations: R-configuration and S-configuration.
4. Functional group:
There are several important functional groups in 5-Methoxytryptamine:
- Aromatic ring: The aromatic ring composed of 6 carbon atoms and 3 double bonds is the core part of the compound structure.
- Amine group: The amine group (NH2) is an amino functional group attached to an aromatic ring, which gives the compound its basic properties.
- Methoxy: Methoxy (CH3O) is a methoxy functional group attached to an aromatic ring.
Through molecular structure analysis, we can obtain information on the molecular composition of 5-Methoxytryptamine, the connection mode between atoms and some important functional groups. This helps us understand the properties and possible reaction behavior of compounds. It should be noted that accurate molecular structure analysis needs to rely on experimental data, such as X-ray diffraction, nuclear magnetic resonance and other techniques to determine the exact structure of the compound.
5-Methoxytryptamine (5-MeO-DMT) was first discovered and synthesized by Austrian chemist Richard Helmuth Fredrick Manske in 1922. At the time, he was studying a plant called Cochlospermum angolense, hoping to extract lysergic acid dimethyl triester (DMT) from it. However, during the extraction process, he discovered a new compound, 5-Methoxytryptamine.

1. Manske performed a preliminary characterization of this new compound and named it "O-Methylserotonin". He noted that 5-Methoxytryptamine has a similar structure to serotonin (serotonin), but has a methoxy group at position 5. The name reflects the methoxy group in the molecule and its relationship to serotonin.
2. With the passage of time, other scientists conducted further research on 5-Methoxytryptamine, and gradually realized its existence and role in living organisms. However, the exact biological function and physiological effects of this compound are still not fully understood, and further studies are needed to gain an in-depth understanding.
In summary, 5-Methoxytryptamine was discovered and synthesized in 1922 by Richard Pena. He named it "O-Methylserotonin" to highlight the methoxy group in the molecule and its structural similarity to serotonin. Subsequent studies have revealed the existence and function of 5-Methoxytryptamine in vivo, but further research is needed on its exact function.
History of 5-Methoxytryptamine Discovery:
1. Early detection:
5-Methoxytryptamine was first synthesized and described in 1922 by Richard Helmuth Fredrick Manske, an Austrian chemist, herbalist and author of books on herbalism. He studied the composition of lysergic acid dimethyl triester by trying to extract it from a plant called Cochlospermum angolense. However, by extracting the obtained impurity products, he discovered a new compound, which is 5-Methoxytryptamine. Manske carried out preliminary characterization of the compound and named it "O-Methylserotonin". He noticed that it was similar in structure to serotonin (serotonin), but had a methoxy group at position 5.
2. Further study:
Research on 5-Methoxytryptamine gradually expanded over time. In the 1940s, scientists began to conduct more in-depth research on its pharmacological activity and physiological effects. Some investigators have found that 5-Methoxytryptamine produces significant effects on the central nervous system similar to other agent analogs such as lysergic acid dimethyltriester (DMT) and dimethyltryptamine (DMA).
3. Identification of biosynthetic pathways:
With the in-depth study of 5-Methoxytryptamine, scientists began to explore its synthesis pathway in organisms. Early studies have shown that 5-Methoxytryptamine can be synthesized through the tryptophan pathway in organisms. Specifically, tryptophan first undergoes a hydroxylation reaction to form 5-hydroxytryptophan, and then undergoes a decarboxylation reaction catalyzed by aromatic-L-amino acid decarboxylase to produce 5-hydroxytryptophan. Finally, 5-HT undergoes a methylation reaction to form 5-Methoxytryptamine. These findings provide a basis for further understanding of the biosynthesis of 5-Methoxytryptamine.
4. Mysterious brain drug:
Although the biosynthetic pathway of 5-Methoxytryptamine has been elucidated to a certain extent, there are still many unsolved mysteries about its exact role and physiological function in organisms. This compound is considered an endogenous neurotransmitter or neuromodulator and is involved in the regulation of multiple neurotransmitter systems. However, detailed studies of its biological effects are limited due to its relatively low levels in vivo and highly sensitive metabolic properties.
It should be noted that 5-Methoxytryptamine is also a drug with potential hallucinogenic effects, which can be synthesized or extracted from natural plants. Thus, as interest in hallucinogen research increased, research on 5-Methoxytryptamine was given a further boost.
To sum up, 5-Methoxytryptamine is an early discovered compound, originally synthesized as a lysergic acid dimethyl triester derivative. Subsequent studies revealed its synthetic pathway in the tryptophan pathway and explored its physiological role in organisms. However, the exact biological function of 5-Methoxytryptamine still needs further research.

